Surgery From 7,000 Miles Away
Remote Robotic Prostatectomy Enters a New Era
Once confined to science fiction, the ability for a world-class surgeon to remove your prostate from across the globe is now a clinical reality — and the technology is moving fast.
Bottom Line Up Front (BLUF)
Robot-assisted radical prostatectomy (RARP) is already the global standard of care for surgically treating localized prostate cancer, accounting for more than 90% of prostatectomies performed in the United States. A new frontier — remote robotic surgery (telesurgery) — now allows a surgeon to operate on a patient hundreds or even thousands of miles away using high-speed fiber optic and 5G networks. In 2025, a Florida surgeon performed the longest-distance prostatectomy ever recorded, operating on a patient in Angola, Africa, from a console in Celebration, Florida — nearly 7,000 miles away — in the first FDA-approved transcontinental telesurgery clinical trial originating in the United States. Studies from China, Kuwait, and the U.S. confirm the procedures can be performed safely, with outcomes comparable to standard local robotic surgery. Challenges remain around latency, regulation, reimbursement, and ethics. Telesurgery is not yet available to most patients, but it holds enormous promise for bringing expert surgical care to underserved regions worldwide — including rural America.
What Is Robotic Prostatectomy — and Why Does It Matter?
When a man with localized prostate cancer chooses surgery, his goal is simple: get the cancer out while preserving as much quality of life as possible — including bladder control and sexual function. For much of the 20th century, this meant open surgery with a large incision. Then came laparoscopy, and eventually robotics — and the world changed.
Robot-Assisted Radical Prostatectomy (RARP) uses a surgeon-controlled robotic system — most often the da Vinci platform made by Intuitive Surgical — to perform the operation through tiny incisions using miniaturized instruments controlled from a nearby console. The surgeon views an extraordinarily detailed, magnified 3-D image of the surgical field and controls robotic arms with tremor-filtered precision that no human hand alone can match.
The results of this shift have been dramatic. More than 90% of radical prostatectomies in the United States are now performed with robotic assistance, and roughly 40% of men with newly diagnosed prostate cancer who choose curative treatment opt for surgical removal of the prostate. Robotic surgery has been shown to reduce blood loss, lower transfusion rates, shorten hospital stays, and speed recovery compared with open surgery, while achieving cancer control outcomes that are at least equivalent.
But here is the challenge: the surgeon has always had to be physically present at the robotic console — typically in the same operating room, or at most in the same building. That is about to change.
What Is Remote Robotic Surgery (Telesurgery)?
Telesurgery — also called remote surgery — separates the surgeon from the patient by transmitting the surgeon's hand and foot movements over a data network to a robotic system located wherever the patient is. The surgeon sees a live video feed from cameras inside the patient's body and operates in real time, with the robot faithfully reproducing every movement at the distant site.
The concept is not new. In 2001, French surgeon Jacques Marescaux performed the famous "Lindbergh Operation," removing a gallbladder from a patient in Strasbourg, France, while operating from New York City. It worked — but the cost of the dedicated telecommunications infrastructure was enormous, latency (signal delay) was barely manageable, and the technology could not be reproduced at scale. The idea stalled for two decades.
What changed everything? 5G wireless networks and modern high-speed fiber optic cable infrastructure. These technologies can transmit data with latencies — the round-trip delay between surgeon movement and robotic response — low enough to make remote surgery both feasible and safe. Critically, a new generation of robotic surgical platforms (many developed in China) has been specifically engineered with telesurgery in mind, reducing costs and increasing availability.
- Latency is the delay between when the surgeon moves a control and when the robot responds. Even a few hundred milliseconds is perceptible.
- Research suggests that latencies below 200–300 milliseconds (0.2–0.3 seconds) are generally acceptable for surgery.
- The China-to-Kuwait telesurgery (December 2024) achieved an average round-trip latency of 181.4 milliseconds over 7,000 km — within safe parameters.
- A large Chinese multicenter study (2023–2024) reported a mean network signal delay of just 55 milliseconds across 37 telesurgery patients.
- The Florida-to-Angola operation used 10,000 miles of direct fiber optic cable running from Orlando to Miami to Brazil and across the Atlantic.
A Brief History of Remote Prostatectomy: From Animal Labs to Angola
Progress in telesurgical prostatectomy has accelerated rapidly over the past three years. Here is how it unfolded:
- 2001 Jacques Marescaux performs the "Lindbergh Operation" — a transatlantic robotic cholecystectomy (gallbladder removal). The procedure succeeds but proves too expensive and technologically fragile to replicate. Telesurgery enters a long dormancy.
- 2022–2023 Chinese surgical teams begin performing remote robotic prostatectomies within China using 5G networks and new domestic robotic platforms (Toumai, Edge). Early results are encouraging.
- November 2023 Dr. Vipul Patel's team at AdventHealth Global Robotics Institute (Orlando, FL) and Chinese colleagues perform telesurgery on a prostate cancer patient in Harbin, China — 1,300 km from Beijing — using the Edge Medical Robot (MP1000). Published in the International Brazilian Journal of Urology, 2024.
- Early 2024 AdventHealth conducts prospective telesurgery studies in live porcine (pig) models between Orlando and Shanghai via Pacific Ocean fiber optic cable, performing 12 remote robotic kidney surgeries. Safety and feasibility confirmed.
- September 2024 First telesurgery robotic procedure between Orlando and São Paulo, Brazil — establishing remote surgical connectivity within the Americas.
- October–April 2022–2024 Zhejiang University (China) conducts a prospective comparative cohort study: 13 patients undergo remote RARP using 5G and novel robotic systems (Tele-RARP); outcomes are compared to 31 patients who had local robotic surgery. All 13 remote procedures completed successfully with no conversions, no intraoperative blood transfusions, and outcomes comparable to local surgery.
- December 2024 First cross-border intercontinental human telesurgery for prostate cancer: A surgeon in Shanghai, China performs RARP on a patient in Kuwait City, Kuwait — approximately 7,000 km away. Reported in the Journal of Robotic Surgery, March 2025. Round-trip latency: 181.4 ms. No complications.
- June 14, 2025 A landmark moment: Dr. Vipul Patel, at AdventHealth Nicholson Center in Celebration, Florida, performs a robotic radical prostatectomy on a 67-year-old Angolan patient — Fernando da Silva — located nearly 7,000 miles away in Luanda, Angola. This is the first FDA-approved human clinical trial of transcontinental robotic telesurgery initiated in the United States. It is the longest-distance telesurgery ever recorded. The patient recovers successfully. ABC News names it one of the top medical breakthroughs of 2025.
- Late 2025 Dr. Patel completes his 20,000th robotic-assisted prostatectomy — the most by any single surgeon in the world. His team completes a total of 10 telesurgery cases from Florida to Angola as part of the FDA-approved clinical trial, with data submitted to the FDA.
Where Is Remote Robotic Prostatectomy Being Performed Today?
As of early 2026, telesurgical prostatectomy has been successfully performed in only a handful of centers worldwide. It is emphatically not yet a routine clinical service anywhere. All procedures have been conducted as part of formal research studies or clinical trials. Here is where the work is happening:
China — The Frontrunner
China has emerged as the global leader in telesurgical volume, driven by two domestically developed platforms: the Toumai Robotic Surgical System (TRSS) and the Edge Medical Robot (MP1000). Both are specifically designed to support remote operation over 5G networks. Chinese researchers at Zhejiang University have published the largest comparative study to date, demonstrating that remote prostatectomy outcomes are equivalent to local robotic surgery in selected patients. A Chinese multicenter study of 37 patients undergoing various 5G telesurgeries (including prostatectomies) reported a 100% surgical success rate with a mean network delay of just 55 milliseconds.
United States — The First FDA-Approved Trial
The AdventHealth Global Robotics Institute in Celebration, Florida — led by Dr. Vipul Patel — is home to the only FDA-approved transcontinental telesurgery trial in the United States. The June 2025 Florida-to-Angola case was a landmark. The FDA granted approval via an Investigational Device Exemption (IDE) clinical trial pathway. Dr. Patel's team used a 17,000-km fiber optic route (Orlando → Miami → Brazil → Angola) that involved no satellite transmission — minimizing latency. A dedicated local surgical team was physically present with the patient throughout the entire procedure as a safety backstop.
Kuwait and the Middle East
The December 2024 Shanghai-to-Kuwait prostatectomy — performed with a surgeon at Toumai headquarters in Shanghai and a patient in Kuwait City — was the first documented cross-border transcontinental human telesurgery for prostate cancer between Asia and the Middle East. It was published in the peer-reviewed Journal of Robotic Surgery in March 2025.
Africa
The Angola case was Africa's first-ever robotic telesurgery. Angola faces one of the highest prostate cancer mortality rates in sub-Saharan Africa, according to the Global Cancer Observatory (GLOBOCAN), largely because of severely limited access to early detection and specialized surgical care. AdventHealth has also helped establish Angola's first national prostate cancer screening program.
A Note on Telementoring
Distinct from telesurgery (where a remote surgeon actually operates) is telementoring, where an expert surgeon in another location guides a local surgeon through a procedure in real time. This application is already farther along in practical deployment and may reach more patients sooner. Dr. Patel sees it as equally transformative: "There was always a big diversity between places that could buy a da Vinci and places that couldn't. Telesurgery and telementoring really help."
How Well Does It Work? What Do the Studies Show?
It is important to be clear: the published evidence base for telesurgical prostatectomy remains small. As of the June 2025 systematic review published in Prostate Cancer and Prostatic Diseases (Nature group), only six studies met formal inclusion criteria, covering just 7 patients who underwent remote robotic prostatectomy over distances ranging from 1 km to 11,412 km. All procedures were completed successfully. But this is very early days.
What we can say from the evidence so far:
All reported remote prostatectomies have been completed without major intraoperative complications or conversion to open surgery. The Zhejiang University comparison study — the most rigorous to date — found no statistically significant differences between the 13 remote surgery patients and the 67 patients who had conventional local robotic surgery in terms of operative outcomes, blood loss, and immediate postoperative results.
The multicenter Chinese study (37 patients, published in Surgical Endoscopy, 2025) found a 100% success rate, no significant adverse events, and surgeon stress levels that were elevated but manageable — a noteworthy finding suggesting psychological demands on the surgeon deserve attention as the field grows.
"As technological progress introduced novel robotic platforms and high-speed networks, the concept of Telesurgery became a tangible reality while 5G technology solved latency and transmission concerns. However, ethical considerations and regulatory frameworks should underline the importance of transparency and patient safety with responsible innovation." — Moschovas, Rogers, Xu, et al., International Brazilian Journal of Urology, 2024
It must be emphasized that long-term data on cancer control, continence, and erectile function after remote prostatectomy do not yet exist. Current publications focus on safety and feasibility — important first steps, but not the full picture. Patients considering any clinical trial in this space should understand that they are part of research, not routine care.
How Good Is Standard (Local) Robotic Prostatectomy? The Baseline That Matters
To properly evaluate remote prostatectomy, patients need to understand the benchmark they are comparing against. Standard local robotic prostatectomy has an established, impressive track record.
Cancer Control
A 15-year study from a Latin American referral center (1,790 patients, 2008–2023) found an estimated 10-year overall survival rate of 97.9% and a 10-year recurrence-free survival of 68.7%. Biochemical recurrence (PSA rising after surgery) occurred in 23.8% over the long follow-up. For lower-risk cancers treated at high-volume centers, outcomes are even better.
Urinary Continence
Most men will have some urinary leakage immediately after prostatectomy. Recovery varies substantially based on technique, patient anatomy, and surgeon experience. In the best published series, using nerve and structure-sparing approaches:
With Retzius-sparing RARP (a specialized technique that preserves the anatomical space in front of the bladder), immediate continence rates have ranged from 38% to 91% in published studies. By one year after surgery, the majority of men achieve good continence. A study using a novel nerve-sparing technique with endopelvic fascia preservation found that 96% of patients achieved pad-free continence by one year. Large real-world series consistently show 85–90% continence rates at 12–24 months. Newer approaches — including single-port transvesical surgery (performed through a single incision through the bladder) — may accelerate recovery further.
Erectile Function
This remains the most variable and challenging outcome. Results depend heavily on age, baseline sexual function, whether one or both nerve bundles can be spared, and the volume of the surgeon's experience. In the best published series with bilateral nerve sparing, satisfactory erectile function was achieved in 97% of patients. Realistically, for the broader population: overall series report satisfactory erectile function in 56–80% at 12–18 months. Men with pre-existing erectile difficulties, older age, or less favorable tumor anatomy will have lower rates.
The "Trifecta" — Getting All Three
The surgical goal after prostatectomy is achieving what urologists call the "trifecta": cancer control, urinary continence, and preserved sexual function — all three at once. Large series report trifecta achievement in approximately 50–60% of patients at two years.
- Surgeon experience profoundly affects outcomes. Studies show it takes 50–100 cases before a robotic surgeon's performance stabilizes.
- In one Turkish study, undetectable PSA rates after surgery improved from 76% in a surgeon's first 50 cases to 90% in their last 50 — a 14% jump — simply from experience.
- When seeking robotic prostatectomy, patients should ask their surgeon about their annual case volume. High-volume surgeons (100+ cases/year) consistently deliver better outcomes.
- Dr. Vipul Patel has now performed over 20,000 robotic prostatectomies — the most of any single surgeon in the world.
The New Robotic Platforms: Competition Is Coming
For two decades, Intuitive Surgical's da Vinci system held a virtual monopoly on robotic prostatectomy. The expiration of key da Vinci patents in 2019 opened the door to competition, and a new generation of systems has now emerged. These include:
Hugo RAS (Medtronic) — A modular system gaining traction in Europe and beyond. Studies show comparable cancer control and functional outcomes to da Vinci, though with higher intraoperative malfunction rates in early data.
Senhance (Asensus Surgical) — A haptic feedback-capable system with studies showing equivalent short-term outcomes to da Vinci, with potentially lower out-of-pocket costs for patients.
Versius (CMR Surgical) — A portable, modular system designed for resource-limited settings.
Toumai (China) and Edge (China) — These are currently the frontrunners specifically in telesurgery capability, having accumulated the most remote prostatectomy cases worldwide.
A 2025 network meta-analysis published in Prostate Cancer and Prostatic Diseases compared outcomes across all major platforms. The headline finding: oncological and functional outcomes — cancer control, continence, and erectile function — were broadly comparable across platforms. This is good news for patients: the robot matters less than the surgeon using it, and the market is becoming more competitive and affordable.
What Are the Challenges and Concerns?
Excitement about telesurgery's potential must be tempered by an honest accounting of the obstacles that remain:
Technical Reliability and Safety
Every telesurgery program to date has required a fully trained local surgical team physically present with the patient throughout the procedure. This is not optional safety theater — it is a genuine requirement. If the data connection is disrupted, a network reroutes, or equipment fails, someone must be able to take over immediately. Dr. Patel was explicit: "I always have my team where the patient is. So in case something happened with telecommunications, the team would just take over and finish the case safely."
Latency and Its Limits
While 5G and fiber optic networks have made low-latency telesurgery possible, latency cannot be reduced to zero over transcontinental distances. Current round-trip delays of 100–300 milliseconds are workable, but surgeons report that operating "feels different" from local surgery. Whether subtle latency effects influence outcomes over thousands of cases remains to be studied.
Regulation
In the United States, the FDA currently requires an Investigational Device Exemption (IDE) for transcontinental telesurgery — meaning it must be conducted as a clinical trial, not routine practice. Cross-border telesurgery involving surgeons and patients in different countries introduces additional legal complexity around medical licensure, liability, and malpractice jurisdiction. These regulatory frameworks are still being developed worldwide.
Reimbursement
No insurance framework yet exists in the U.S. or elsewhere for reimbursing telesurgery — a major barrier to widespread clinical deployment outside of trials.
Ethics
Thoughtful researchers have raised concerns about the potential for telesurgery to "dehumanize" the patient-surgeon relationship. The surgeon-patient bond built through direct consultation, physical examination, and shared decision-making is a core element of surgical care. Remote surgery challenges this bond and requires deliberate attention to informed consent, transparency, and communication about risks the patient may not fully anticipate.
Infrastructure Access
The cruel irony of telesurgery for global health equity is that the populations who most need expert surgical access — in rural Africa, rural America, and other resource-limited regions — are often the same populations least likely to have the fiber optic connectivity and power infrastructure that telesurgery requires at the receiving end.
What This Means for Prostate Cancer Patients Today
If you are a patient considering robotic prostatectomy now: Remote telesurgery is not available to you as a standard treatment option. What you can access is a robustly proven, highly effective robotic prostatectomy at an experienced center. The key decisions you should focus on are: choosing a high-volume surgeon and institution, understanding the surgical approach offered (standard vs. Retzius-sparing vs. single-port), and having a thorough conversation about expected outcomes for your specific situation.
If you live in a rural or underserved area of the United States and lack access to an experienced robotic surgeon: The telesurgery landscape does directly concern you. Dr. Patel himself emphasized that the United States has "huge underserved areas in rural America" where hospital systems lack specialized cancer surgery. Remote robotic surgery — and telementoring — may eventually allow world-class surgical expertise to reach those communities. This is not today's reality, but it is the near-term trajectory.
If you are following developments in AI and robotics in prostate surgery: The field is also advancing in complementary directions. Machine learning models are now being trained on tens of thousands of individual surgical gestures during robotic prostatectomy to identify which movements correlate with better outcomes for continence and potency. AI is being used to predict individual patients' post-surgical functional outcomes before the knife falls. Augmented reality, fluorescence imaging, and automated surgical video analysis are all in active development. The robotic prostatectomy of 2030 may look very different from today's.
"This is more than innovation. It is a humanitarian leap forward." — Vipul Patel, MD, Medical Director, Global Robotics Institute, AdventHealth Celebration, June 2025
Summary: What We Know and What We Don't
What we know: Standard robotic prostatectomy is safe, effective, and the dominant surgical treatment for localized prostate cancer. Remote robotic prostatectomy has been successfully performed on humans at distances up to nearly 7,000 miles using 5G and fiber optic networks. Early safety and feasibility data are encouraging. A 100% procedural success rate has been reported across published series. The FDA has approved the first U.S.-based transcontinental telesurgery clinical trial.
What we don't know: Whether remote prostatectomy produces equivalent long-term cancer control, continence, and erectile function outcomes compared with in-person robotic surgery. Whether the technology can be safely and economically scaled to routine clinical use. How regulatory, liability, and reimbursement frameworks will evolve. And critically — whether the local infrastructure needed at the patient's end (reliable high-speed connectivity, trained local surgical team, appropriate OR equipment) can realistically be deployed in the most medically underserved areas of the world.
The story of remote robotic prostatectomy is one of the most exciting in all of medicine right now. The IPCSG will continue to follow it closely and report developments as they occur.
Verified Sources and Formal Citations
-
Westerman ME. Robotic Prostatectomy: A Game-Changer in Prostate Cancer Treatment. AUA News. February 2, 2024.
https://auanews.net/issues/articles/2024/february-2024/robotics-robotic-prostatectomy-a-game-changer-in-prostate-cancer-treatment -
Aldousari S, Almarzouq A, Hassan A, et al. The
era of telesurgery: insights from ultra-long-distance Asia to Middle
East human telesurgery robotic-assisted radical prostatectomy. Journal of Robotic Surgery. 2025;19(1):108. doi:10.1007/s11701-025-02274-9
https://pmc.ncbi.nlm.nih.gov/articles/PMC11893634/ -
[Authors pending final publication]. Telesurgery in prostate cancer: a systematic review of clinical applications and future directions. Prostate Cancer and Prostatic Diseases. Published online 2026. doi:10.1038/s41391-026-01090-y
https://www.nature.com/articles/s41391-026-01090-y -
Ye S, Peng D, Zhu L, et al. 5G-remote radical prostatectomy under novel robotic systems: a prospective comparative cohort study with local surgeries. Prostate Cancer and Prostatic Diseases. 2025. doi:10.1038/s41391-025-01004-4
https://pubmed.ncbi.nlm.nih.gov/40721878/ -
Moschovas MC, Rogers T, Xu W, Perera R, Zhang X, Patel V. First impressions of Telesurgery robotic-assisted radical prostatectomy using the Edge medical robotic platform. International Brazilian Journal of Urology. 2024;50(6):754–763. doi:10.1590/S1677-5538.IBJU.2024.0458
https://pubmed.ncbi.nlm.nih.gov/39226445/ -
Yu S, Tao J, Guo B, et al. Application of 5G robotic telesurgery in urology: a multicenter study in the real world. Surgical Endoscopy. 2025;39:5613–5622. doi:10.1007/s00464-025-11969-x
https://link.springer.com/article/10.1007/s00464-025-11969-x -
Bertolo R, Veccia A, Antonelli A. Democratizing robotic prostatectomy: navigating from novel platforms, telesurgery, and telementoring. Prostate Cancer and Prostatic Diseases. 2025;28(2):241–242. doi:10.1038/s41391-024-00812-4
https://www.nature.com/articles/s41391-024-00812-4 -
AdventHealth. Historic telesurgery connects Central Florida and Angola in world-first medical breakthrough. AdventHealth News. June 23, 2025.
https://www.adventhealth.com/news/historic-telesurgery-connects-central-florida-and-angola-world-first-medical-breakthrough -
Patel V. Forging New Frontiers in Telesurgery to Improve Global Health Access, Outcomes and Equity. AdventHealthMD (Clinician's View). August 4, 2025.
https://www.adventhealth.com/medical/adventhealthmd/blog/forging-new-frontiers-telesurgery-improve-global-health-access-outcomes-and-equity -
American College of Surgeons. Fellow Leads Groundbreaking Prostatectomy on Patient 7,000 Miles Away. ACS Brief. June 24, 2025.
https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/acs-brief/june-24-2025-issue/fellow-leads-groundbreaking-prostatectomy-on-patient-7-000-miles-away/ -
AdventHealth Research Institute. Dr. Vipul Patel Performs the Longest Distance Telesurgery Ever Completed. August 6, 2025.
https://www.adventhealth.com/institute/adventhealth-research-institute/news/dr-vipul-patel-performs-longest-distance-telesurgery-ever-completed -
International Prostate Cancer Foundation. Dr. Vipul Patel, IPCF founder, completes a historic remote telesurgery across 17,000 kilometers of fiber optic distance. June 27, 2025.
https://www.fightingprostatecancer.org/blog/2025/6/17/im7msshklq0ulin8y6pw62qn397dsi -
ABC News. Exclusive look at groundbreaking remote robotic surgery: Patient was in Africa; doctor was in Florida. June/August 2025.
https://abcnews.com/Health/exclusive-groundbreaking-remote-robotic-surgery-patient-africa-doctor/story?id=122946197 -
AdventHealth. Expanding access to care through record-setting remote robotic surgery at AdventHealth Celebration recognized by ABC News. January 2, 2026.
https://www.adventhealth.com/news/expanding-access-care-through-record-setting-remote-robotic-surgery-adventhealth-celebration -
Mian AH, Tollefson MK, Shah P, et al. Navigating Now and Next: Recent Advances and Future Horizons in Robotic Radical Prostatectomy. Journal of Clinical Medicine. 2024;13(2):359. doi:10.3390/jcm13020359
https://pubmed.ncbi.nlm.nih.gov/38256493/ -
[Authors]. Novel nerve-sparing
robot-assisted radical prostatectomy with endopelvic fascia preservation
and long-term outcomes for a single surgeon. Scientific Reports. 2024. doi:10.1038/s41598-024-51598-3
https://www.nature.com/articles/s41598-024-51598-3 -
[Authors]. Outcomes of robot-assisted
radical prostatectomy with novel robotic platforms vs da Vinci
multiport systems: a systematic review and network meta-analysis. Prostate Cancer and Prostatic Diseases. 2025. doi:10.1038/s41391-025-01023-1
https://www.nature.com/articles/s41391-025-01023-1 -
Oncologic and functional outcomes following robot assisted
radical prostatectomy: 15-Year experience in a Latin American referral
center. ScienceDirect. Published September 2024.
https://www.sciencedirect.com/science/article/abs/pii/S0960740424001063 -
Saikali S, Reddy S, Gokaraju M, et al. Development
and Assessment of an AI-based Machine Learning Model for Predicting
Urinary Continence and Erectile Function Recovery after Robotic-Assisted
Radical Prostatectomy. Computer Methods and Programs in Biomedicine. 2025;259:108522. doi:10.1016/j.cmpb.2024.108522
https://pubmed.ncbi.nlm.nih.gov/39626503/ -
Patel V, Klaassen Z. First Cross-Continent Robotic Prostatectomy Performed Using Tele-Surgery [Video interview]. UroToday. 2025.
https://www.urotoday.com/video-lectures/prostate-cancer/video/mediaitem/5014-first-cross-continent-robotic-prostatectomy-performed-using-tele-surgery-vipul-patel.html -
American College of Surgeons. Advanced Imaging, Robotic Surgery Propel Prostate Cancer Management. Bulletin of the American College of Surgeons. July/August 2025.
https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/bulletin/2025/julyaugust-2025-volume-110-issue-7/advanced-imaging-robotic-surgery-propel-prostate-cancer-management/ -
AdventHealth Global Robotics Institute. Program overview and telesurgery milestones.
https://globalrobotics.adventhealth.com/global-robotics-institute
Comments
Post a Comment